Drug Pipeline

Mesenchymal Stem Cells (MSCs) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 1/2
1
Phase 1
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07265349 A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of… Coronary Artery Bypass Grafting (CABG) Recruiting
Phase 1
NCT05925036 Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis Chronic Pancreatitis Recruiting
NCT04061746 Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells Diabetes Mellitus, Type 1 Active, Not Recruiting
Early Phase 1
NCT06205342 Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain Chronic Pancreatitis Recruiting
Sponsors Running Mesenchymal Stem Cells (MSCs) Trials
Medical University of South Carolina (2) VA Office of Research and Development (1) Tasly Pharmaceutical Group Co., Ltd (1)
Disease Areas
Diabetes (1) Heart Failure (1)
Get alerts when Mesenchymal Stem Cells (MSCs) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free